Hygieia appointed Doug Lawrence its chief executive officer, responsible for leading operations, development, and global growth of the company and its d-Nav Insulin Management Program. The company noted that Lawrence brings three decades of medical technology leadership to his new role at Hygieia, including significant experience bringing products to market, restructuring and guiding companies through mergers and acquisitions, building global sales teams, raising venture capital, and overseeing operations. Lawrence is an experienced CEO who previously led three companies including CeQur, a company that makes insulin patch pumps to treat type 2 diabetes.

Previously, he led the diabetes business at Becton Dickinson (now Embecta), the world's leading manufacturer of insulin syringes and pen needles.